Detalhe da pesquisa
1.
Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?
Blood
; 2024 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38728380
2.
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study.
Br J Haematol
; 204(4): 1450-1458, 2024 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-37953476
3.
Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study.
Lancet
; 401(10392): 1941-1950, 2023 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37105210
4.
Infectious risks in patients treated with extracorporeal photopheresis for graft-versus-host disease: A retrospective cohort study.
J Clin Apher
; 37(1): 106-116, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34967023
5.
Splenectomy before allogeneic hematopoietic cell transplantation for myelofibrosis: A French nationwide study.
Am J Hematol
; 96(1): 80-88, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33108024
6.
Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study.
Blood
; 132(7): 750-754, 2018 08 16.
Artigo
Inglês
| MEDLINE | ID: mdl-29760162
7.
R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma.
Blood
; 131(2): 174-181, 2018 01 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29061568
8.
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Ann Hematol
; 98(8): 1973-1980, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31111177
9.
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA study.
Br J Haematol
; 181(3): 341-349, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29611187
10.
Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire.
Am J Hematol
; 93(3): 416-423, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29226497
11.
Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial.
Lancet
; 387(10036): 2402-11, 2016 Jun 11.
Artigo
Inglês
| MEDLINE | ID: mdl-27080498
12.
Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies.
Biol Blood Marrow Transplant
; 22(2): 240-247, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26256942
13.
Impact of ATG Dose on the Outcome of Patients Undergoing Reduced Intensity Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
Acta Haematol
; 136(4): 193-200, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27623172
14.
Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie Cellulaire.
Biol Blood Marrow Transplant
; 21(8): 1515-23, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25958294
15.
Decreased nonrelapse mortality after unrelated cord blood transplantation for acute myeloid leukemia using reduced-intensity conditioning: a prospective phase II multicenter trial.
Biol Blood Marrow Transplant
; 21(3): 445-53, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25460357
16.
New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation.
Blood
; 121(6): 1059-64, 2013 Feb 07.
Artigo
Inglês
| MEDLINE | ID: mdl-23247725
17.
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
Eur J Haematol
; 94(3): 265-9, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25130897
18.
Worsening of respiratory status during neutropenia recovery in noncritically ill hematological patients: results of a prospective multicenter study.
Respiration
; 90(3): 229-34, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26278709
19.
Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Biol Blood Marrow Transplant
; 20(9): 1349-55, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24838178
20.
Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome: a study from the French Society of Bone Marrow Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 20(5): 646-54, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24462982